Abstract The European Society of Gynaecological Oncology (ESGO), the International
Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study …

Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

Skin cancer, including both melanoma and non-melanoma, is the most common type of
malignancy in the Caucasian population. Firstly, we review the evidence for the observed …

Background: This study sought to determine the prevaccine type-specific prevalence of
human papillomavirus (HPV)–associated cancers in the United States to evaluate the …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …

Background The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background Little information has been reported on regional and time trends of human
papillomavirus (HPV) prevalence rates of oropharyngeal cancer (OPC) and non‐OPC …